X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result

hubXchange – the San Diego Series

Organised by HUB XCHANGE LIMITED
February 19 - February 25, 2025
Handlery Hotel San Diego, 950 Hotel Circle North, San Diego, CA, 92108
California - USA,

Handlery Hotel San Diego, 950 Hotel Circle North, San Diego, CA, 92108 , California, USA

hubXchange’s Roundtable Series redefines industry events by offering a uniquely intimate and senior-level platform for meaningful engagement.

Focused Roundtable Discussions: Participate in targeted discussions alongside C-level executives and senior scientists, addressing the most pressing challenges in Antibody Therapeutics, Immunotherapies, AI in Drug Discovery, and Advanced Therapies.

Expertly Curated Events: Our one-day programs are tailored to deliver actionable insights while maximizing efficiency for busy professionals.

Personalized Agendas: Every attendee receives a custom-crafted agenda, thoughtfully designed to align with individual goals and priorities.

Pre-Booked 1:1 Meetings: Benefit from dedicated meeting slots with hand-selected service providers, facilitating strategic partnerships and productive conversations.

Pre-Qualified Attendees: Network with a carefully curated group of professionals, ensuring the highest level of dialogue and collaboration.

hubXchange’s format fosters collaboration and connections that last well beyond the event. By combining unrivaled networking opportunities with focused, solution-driven discussions, we help you drive innovation forward.

 

Event Name: hubXchange’s Life Science Roundtable Events – San Diego 2025
Event Date: 19th, 20th, 24th, 25th February 2025
Event Venue: Handlery Hotel San Diego, 950 Hotel Circle North, San Diego, CA, 92108
Event Organizers: hubXchange
Contact Number (with country & area code): +44 20 3371 9932
Email: nathan@hub-xchange.com
URL:

  • Antibody Therapeutics Xchange | 19th Feb, 2025 | https://bit.ly/49KaMDe
  • Immunotherapies Xchange | 20th Feb, 2025 | https://bit.ly/3ZZ2Udq
  • AI in Drug Discovery Xchange | 24th Feb, 2025 | https://bit.ly/3Bzgif6
  • Advanced Therapies Xchange | 25th Feb, 2025 | https://bit.ly/3DliXcO

Enquiry

Latest

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In